Volume 2 - Issue 2, Winter 2008 - Industry News: An Overview of the Latest Updates from Technology & Industry

Cypher Sirolimus- Eluting Coronary Stent Comparable to Bypass Surgery

Cordis have released clinical data indicating that percutaneous coronary intervention with the CYPHER sirolimuseluting coronary stent is comparable to bypass surgery in key safety measures in patients with diabetes and multi-vessel disease.
The data was recently presented at the European Society of Cardiology meeting. It is the only drug-eluting stent with such randomised clinical data indicating that it is comparable to bypass surgery for these specific patients. The study showed that after one year no difference from bypass surgery in terms of death, heart attacks or stroke was found. The trial was conducted at 24 medical centres throughout the UK and Ireland.

Print as PDF
Cordis have released clinical data indicating that percutaneous coronary intervention with the CYPHER sirolimuseluting coronary stent is comparable to bypa

No comment


Please login to leave a comment...